From the aDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
bCenter for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
cDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
dDivision of Research, Kaiser Permanente Northern California, Oakland, CA.
Submitted January 23, 2019; accepted September 23, 2019.
This project was funded by the FDA through Sentinel contract number HHSF223200910006I.
The authors report no conflicts of interest.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Software for the methods discussed in the manuscript is available at https://github.com/richiewyss/tdps-conditionalHR.
Correspondence: Richard Wyss, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, 1620 Tremont St. Suite 3030, Boston, MA 02120. E-mail: [email protected].